Blackrock Neurotech

Blackrock Neurotech is a neurotechnology company based in Salt Lake City, Utah, focused on developing brain-computer interface (BCI) systems. Founded in 2008, the company has a strong legacy in innovation, stemming from the invention of the Utah Electrode Array. Blackrock Neurotech aims to restore function and independence for individuals with neurological disorders, paralysis, or limb loss. The flagship product, the Utah Array, is a grid of electrodes that records signals from neurons and stimulates brain tissue. This technology allows users to control devices like robotic limbs and computers directly with their thoughts. Blackrock is also developing a fully implantable wireless system to enhance usability and reduce infection risks. Their MoveAgain BCI device helps patients regain independence by enabling control of assistive technologies through thought. Blackrock Neurotech supports over 1,000 research labs globally and has contributed to more than 2,000 published studies. Their systems are used in clinical trials to assist patients with various neurological conditions, enabling them to perform tasks such as typing, operating robotic arms, and creating art.

• Employees 200
• Founded 2008
• Annual Revenue $37000000
• Total Funding $32368642